Cutting edge: Monarch-1: A pyrin/nucleotide-binding domain/leucine-rich repeat protein that controls classical and nonclassical MHC class I genes

Journal of Immunology

Volumn 170, Issue 11, 2003, Pages 5354-5358

  Williams, Kristi L ^a   Taxman, Debra J ^a   Linhoff, Michael W ^a   Reed, William ^a   Ting, Jenny P Y ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; GENE PRODUCT; LEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONARCH 1 PROTEIN; NUCLEOTIDE BINDING PROTEIN; PURINE; PYRIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CATERPILLER GENE; CONTROLLED STUDY; GENE; GENE CONTROL; HUMAN; HUMAN CELL; MULTIGENE FAMILY; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION;

EID: 0037852184     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.11.5354     Document Type: Article

References (22)

1. Harron, J. A., M. W. Linhoff, J. Zhang, and J. P. Ting. 2002. Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotidebinding, and leucine-rich repeat domains. J. Immunol. 169:4088.
2. Hoffman, H. M., J. L. Mueller, D. H. Broide, A. A. Wanderer, and R. D. Kolodner. 2001. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29:301.
3. Wang, L., G. A. Manji, J. M. Grenier, A. Al-Garawi, S. Merriam, J. M. Lora, B. J. Geddes, M. Briskin, P. S. DiStefano, and J. Bertin. 2002. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-κB and caspase1-dependent cytokine processing. J. Biol. Chem. 277:29874.
4. Manji, G. A., L. Wang, B. J. Geddes, M. Brown, S. Merriam, A. Al-Garawi, S. Mak, J. M. Lora, M. Briskin, M. Jurman, et al. 2002. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-κB. J. Biol. Chem. 277:11570.
5. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
6. Miceli-Richard, C., S. Lesage, M. Rybojad, A. M. Prieur, S. Manouvrier-Hanu, R. Hafner, M. Chamaillard, H. Zouali, G. Thomas, and J. P. Hugot. 2001. CARD15 mutations in Blau syndrome. Nat. Genet. 29:19.
7. Ogura, Y., D. K. Bonen, N. Inohara, D. L. Nicolae, F. F. Chen, R. Ramos, H. Britton, T. Motan, R. Karaliuskas, R. H. Duerr, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603.
8. Hugot, J. P., M. Chamaillard, H. Zouali, S. Lesage, J. P. Cezard, J. Belaiche, S. Almer, C. Tysk, C. A. O'Morain, M. Gassull, et al. 2001. Association of NODC leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599.
9. Beutler, B. 2001. Autoimmunity and apoptosis: the Crohn's connection. Immunity 15:5.
10. Feldmann, J., A. M. Prieur, P. Quartier, P. Betquin, S. Certain, E. Cottis, D. Teillac-Hamel, A. Fischer, and G. de Saint Basile. 2002. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am. J. Hum. Genet. 71:198.
11. Dode, C., N. Le Du, L. Cuisset, F. Letourneur, J. M. Berthelot, G. Vaudour, A. Meyrier, R. A. Watts, D. G. Scott, A. Nicholls, et al. 2002. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am. J. Hum. Genet. 70:1498.
12. Ogura, Y., N. Inohara, A. Benito, F. F. Chen, S. Yamaoka, and G. Nunez. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276:4812.
13. Martin, B. K., K. C. Chin, J. C. Olsen, C. A. Skinner, A. Dey, K. Ozato, and J. P. Ting. 1997. Induction of MHC class I expression by the MHC class II transactivator CHTA. Immunity 6:591.
14. Shami, P. J., N. Kanai, L. Y. Wang, T. M. Vreeke, and C. H. Parker. 2001. Identification and characterization of a novel gene that is upregulated in leukaemia cells by nitric oxide. Br. J. Haematol. 112:138.
15. Gobin, S. J., and P. J. van den Elsen. 1999. The regulation of HLA class I expression: is HLA-G the odd one out? Semin. Cancer Biol. 9:55.
16. Masumoto, J., S. Taniguchi, K. Ayukawa, H. Sarvotham, T. Kishino, N. Niikawa, E. Hidaka, T. Katsuyama, T. Higuchi, and J. Sagara. 1999. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J. Biol. Chem 274:33835.
17. Onno, M., G. Le Friec, C. Pangault, L. Amiot, V. Guilloux, B. Drenou, S. Caulet-Maugendre, P. Andre, and R. Fauchet. 2000. Modulation of HLA-G antigens expression in myelomonocytic cells. Hum. Immunol. 61:1086.
18. Wainwright, S. D., P. A. Biro, and C. H. Holmes. 2000. HLA-F is a predominantly empty, intracellular, TAP-associated MHC class 1b protein with a restricted expression pattern. J. Immunol. 164:319.
19. Le Bouteiller, P., and A. Blaschitz. 1999. The functionality of HLA-G is emerging. Immunol. Rev. 167:233.
20. Howcroft, T. K., J. C. Richardson, and D. S. Singer. 1993. MHC class I gene expression is negatively regulated by the proto-oncogene, c-jun. EMBO J. 12:3163.
21. Solier, C., V. Mallet, F. Lenfant, A. Bertrand, A. Huchenq, and P. Le Bouteiller. 2001. HLA-G unique promoter region: functional implications. Immunogenetics 53:617.
22. Trowsdale, J. 2001. Genetic and functional relationships between MHC and NK receptor genes. Immunity 15:363.